PUBLISHER: The Business Research Company | PRODUCT CODE: 1942777
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942777
The edge-GPU breast tomosynthesis box is an advanced imaging system that integrates high-performance edge computing with breast tomosynthesis technology. It facilitates rapid, high-resolution 3D breast imaging by processing large data volumes locally at the edge, minimizing latency and reducing dependence on centralized servers. The system typically includes GPU-powered workstations, specialized detectors, and advanced imaging software to enhance diagnostic precision. It is extensively utilized in healthcare environments for early detection and accurate evaluation of breast abnormalities, contributing to improved workflow efficiency and better patient outcomes.
The primary product types of edge-GPU breast tomosynthesis boxes include standalone edge-GPU boxes and integrated edge-GPU systems. A standalone edge-GPU box is an independent computing device designed to handle high-performance data processing at the network edge. These products are distributed through multiple channels, including direct sales, distributors, online platforms, and others. They are used across various applications such as breast cancer screening, diagnostic imaging, research and development, among others, and serve end-users including hospitals, diagnostic centers, and research institutes.
Tariffs have influenced the edge-gpu breast tomosynthesis box market by increasing costs for gpu hardware, imaging detectors, and computing modules. Segments most affected include standalone and integrated systems, especially in North America and Europe. Positive effects include promotion of local assembly and innovation in high-performance imaging solutions.
The edge-gpu breast tomosynthesis box market research report is one of a series of new reports from The Business Research Company that provides edge-gpu breast tomosynthesis box market statistics, including edge-gpu breast tomosynthesis box industry global market size, regional shares, competitors with a edge-gpu breast tomosynthesis box market share, detailed edge-gpu breast tomosynthesis box market segments, market trends and opportunities, and any further data you may need to thrive in the edge-gpu breast tomosynthesis box industry. This edge-gpu breast tomosynthesis box market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The edge-gpu breast tomosynthesis box market size has grown rapidly in recent years. It will grow from $0.53 billion in 2025 to $0.61 billion in 2026 at a compound annual growth rate (CAGR) of 13.3%. The growth in the historic period can be attributed to adoption of breast tomosynthesis technology, development of edge-gpu computing, demand for high-resolution 3D imaging, growth of breast cancer screening programs, advances in imaging detectors.
The edge-gpu breast tomosynthesis box market size is expected to see rapid growth in the next few years. It will grow to $0.99 billion in 2030 at a compound annual growth rate (CAGR) of 13.0%. The growth in the forecast period can be attributed to AI-driven diagnostic tools, expansion of portable screening units, integration with cloud imaging platforms, faster image processing capabilities, increased adoption in research and clinical settings. Major trends in the forecast period include real-time 3D imaging, gpu-accelerated processing, enhanced diagnostic accuracy, ai-based image analysis, portable imaging solutions.
The increasing prevalence of breast cancer is anticipated to drive the growth of the edge-GPU breast tomosynthesis box market in the coming years. Breast cancer occurs when abnormal cells in the breast multiply uncontrollably, forming malignant tumors that can spread to other areas of the body. Early detection through advanced imaging methods significantly improves treatment outcomes and survival rates. The rise in breast cancer cases can be attributed to lifestyle changes, including poor diet, reduced physical activity, and hormonal factors that heighten the risk of abnormal cell growth. The edge-GPU breast tomosynthesis box plays a vital role in addressing this challenge by offering high-resolution 3D imaging that enables early and precise tumor detection, enhances diagnostic accuracy, and allows faster image processing to support efficient treatment planning. For example, according to the World Health Organization (WHO) in August 2025, breast cancer was the most common cancer among women in 157 of 185 countries in 2022, accounting for approximately 99% of cases in women and 0.5-1% in men. Therefore, the rising incidence of breast cancer is contributing to the increasing demand for edge-GPU breast tomosynthesis boxes.
Companies operating in the edge-GPU breast tomosynthesis box market are focusing on advancing image processing technologies to deliver greater image clarity, reduce scan times, and enhance diagnostic precision in breast cancer screening. Accelerated image processing utilizes high-performance GPUs and specialized computing systems to rapidly reconstruct, analyze, and visualize complex imaging data, improving efficiency and accuracy in clinical workflows. For instance, in June 2025, QT Imaging, Inc., a U.S.-based medical device company, introduced next-generation breast imaging reconstruction software powered by NVIDIA L40 GPU acceleration. This innovation offers faster image processing, improved diagnostic precision, and enhanced workflow efficiency, marking a major advancement in breast imaging technology. The solution aims to streamline breast cancer screening and deliver more accurate and timely diagnostic outcomes, ultimately improving patient care.
In July 2025, RadNet, Inc., a U.S.-based leading provider of outpatient diagnostic imaging services, acquired iCAD, Inc. for an undisclosed amount. This acquisition aims to strengthen RadNet's advanced imaging and diagnostic capabilities by integrating iCAD's innovative cancer detection technologies. The collaboration enhances early detection, improves workflow efficiency, and supports better patient outcomes. iCAD, Inc. is a U.S.-based medical technology company known for its development of edge-GPU breast tomosynthesis systems.
Major companies operating in the edge-gpu breast tomosynthesis box market are Hologic Inc., GE Healthcare, Fujifilm Holdings Corporation, Siemens Healthineers, Canon Medical Systems Corporation, Planmed Oy, Metaltronica S.p.A., General Medical Merate (IMS GIOTTO), Villa Sistemi Medicali, DMS Imaging, DRTECH Corporation, Stephanix, Delphinus Medical Technologies, Konica Minolta, Carestream Health, Agfa-Gevaert N.V., IDETEC Medical Imaging, Xenox (Xenox Medical), Aurora Imaging Technology, Micrima Ltd., Neusoft Medical Systems, Landwind Medical
North America was the largest region in the edge-GPU breast tomosynthesis box market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the edge-gpu breast tomosynthesis box market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the edge-gpu breast tomosynthesis box market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The edge-GPU breast tomosynthesis box market consists of revenues earned by entities by providing services such as enhanced image quality services, reduced radiologist workload services, compliance with regulatory standards services, real-time image reconstruction services, and mobile and point-of-care deployment. The market value includes the value of related goods sold by the service provider or included within the service offering. The edge-GPU breast tomosynthesis box market also includes sales of tomosynthesis scanner, imaging detector, networking hardware, storage device, and imaging workstation. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Edge-GPU Breast Tomosynthesis Box Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses edge-gpu breast tomosynthesis box market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for edge-gpu breast tomosynthesis box ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The edge-gpu breast tomosynthesis box market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.